Innova Captab Q4 Results
- BSE: 544067
- NSE: INNOVACAP
- ISIN: INE0DUT01020
- Sector: Biotechnology & Drugs
BSE
683.95
-5.90 (-0.86%)
-5.90 (-0.86%)Volume1.02 K
Updated: Mon 13 Apr, 2026 | 15:29:52
NSE
682.20-7.15 (-1.04%)
-7.15 (-1.04%)Volume32.47 K
Updated: Mon 13 Apr, 2026 | 15:30:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Innova Captab Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 276.86 | 392.32 | 0.66% | 227.96 | 21.45% |
| Depreciation/ Amortization | 9.80 | 11.42 | 91.00% | 3.41 | 187.79% |
| Operating Income | 37.88 | 57.97 | -8.56% | 34.67 | 9.26% |
| Net Income | 29.57 | 42.15 | -13.54% | 28.72 | 2.97% |
| Net Income Before Taxes | 39.31 | 55.68 | -13.77% | 39.55 | -0.59% |
| Other Operating Expenses Total | 33.52 | 45.30 | 5.52% | 30.39 | 10.28% |
| Total Revenue | 314.74 | 450.29 | -0.54% | 262.63 | 19.84% |
| Selling/ General/ Admin Expenses Total | 35.52 | 43.78 | 25.90% | 25.90 | 37.15% |
| Diluted Normalized EPS | 5.16 | 7.37 | -13.51% | 9.38 | -44.96% |